arginine and Dysmyelopoietic Syndromes

arginine has been researched along with Dysmyelopoietic Syndromes in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (22.22)	18.7374
1990's	4 (44.44)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (22.22)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Aluri, S; Bhatia, R; Cable, L; Chen, Y; Deng, H; Guo, H; Han, X; Iancu-Rubin, C; Jiang, M; Jin, J; Jin, S; Klug, CA; Krause, DS; Liu, J; Liu, SM; Luo, M; Nimer, SD; Qu, CK; Senevirathne, C; Shen, Y; Su, H; Sun, CW; Tran, NT; Verma, A; Xavier-Ferrucio, J; Xiang, J; Zhang, T; Zhao, Q; Zhao, X; Zheng, YG; Zhu, Y	1
Čermák, J; Chrastinová-Mášová, L; Dyr, JE; Pimková, K; Štikarová, J; Suttnar, J	1
Joshi, D; Korgaonkar, S; Shanmukhaiah, C; Vundinti, BR	1
Chalevelakis, G; Yalouris, AG	1
Ferrini, PR; Santini, V	1
Kauma, H; Timonen, TT	1
Knuutila, S; Ruutu, T; Tenhunen, R; Volin, L	1
Ruutu, T; Tenhunen, R; Volin, L	1
Felix, CA; Hosler, MR; Lange, BJ; Masterson, M; Wilson, AE; Winick, NJ	1

Reviews

1 review(s) available for arginine and Dysmyelopoietic Syndromes

Article	Year
Differentiation therapy of myelodysplastic syndromes: fact or fiction? British journal of haematology, 1998, Volume: 102, Issue:5 Topics: Acetamides; Amifostine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arginine; Azacitidine; Butyrates; Cholecalciferol; Cytarabine; Harringtonines; Hematopoietic Cell Growth Factors; Heme; Homoharringtonine; Humans; Interferons; Myelodysplastic Syndromes; Retinoids	1998

Article

Year

Differentiation therapy of myelodysplastic syndromes: fact or fiction?

British journal of haematology, 1998, Volume: 102, Issue:5

Topics: Acetamides; Amifostine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arginine; Azacitidine; Butyrates; Cholecalciferol; Cytarabine; Harringtonines; Hematopoietic Cell Growth Factors; Heme; Homoharringtonine; Humans; Interferons; Myelodysplastic Syndromes; Retinoids

1998

Other Studies

8 other study(ies) available for arginine and Dysmyelopoietic Syndromes

Article	Year
Methylation of dual-specificity phosphatase 4 controls cell differentiation. Cell reports, 2021, 07-27, Volume: 36, Issue:4 Topics: Adult; Animals; Arginine; Cell Differentiation; Cell Line; Child; Dual-Specificity Phosphatases; Enzyme Stability; Female; HEK293 Cells; Humans; Male; MAP Kinase Signaling System; Megakaryocytes; Methylation; Mice, Inbred C57BL; Middle Aged; Mitogen-Activated Protein Kinase Phosphatases; Myelodysplastic Syndromes; p38 Mitogen-Activated Protein Kinases; Polyubiquitin; Protein-Arginine N-Methyltransferases; Proteolysis; Repressor Proteins; Ubiquitination; Young Adult	2021
Enhanced levels of asymmetric dimethylarginine in a serum of middle age patients with myelodysplastic syndrome. Journal of hematology & oncology, 2013, Aug-19, Volume: 6 Topics: Adult; Arginine; Case-Control Studies; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Oxidative Stress	2013
Association of XPD (Lys751Gln) and XRCC1 (Arg280His) gene polymorphisms in myelodysplastic syndrome. Annals of hematology, 2016, Volume: 95, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Case-Control Studies; DNA-Binding Proteins; Female; Genetic Association Studies; Glutamine; Histidine; Humans; Lysine; Male; Middle Aged; Myelodysplastic Syndromes; Polymorphism, Single Nucleotide; X-ray Repair Cross Complementing Protein 1; Xeroderma Pigmentosum Group D Protein; Young Adult	2016
Haem administration in myelodysplastic syndromes: a possible mechanism of action. European journal of haematology, 1993, Volume: 51, Issue:1 Topics: alpha-Thalassemia; Arginine; beta-Thalassemia; Globins; Heme; Humans; Myelodysplastic Syndromes; Reticulocytes	1993
Therapeutic effect of heme arginate in myelodysplastic syndromes. European journal of haematology, 1992, Volume: 49, Issue:5 Topics: Adult; Aged; Alanine Transaminase; Arginine; Aspartate Aminotransferases; Bone Marrow; Creatinine; Erythropoietin; Female; Heme; Humans; Karyotyping; Male; Middle Aged; Myelodysplastic Syndromes	1992
Heme arginate treatment for myelodysplastic syndromes. Leukemia research, 1988, Volume: 12, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Arginine; Blood Cell Count; Female; Heme; Humans; Karyotyping; Male; Middle Aged; Myelodysplastic Syndromes	1988
Haem arginate as a treatment for myelodysplastic syndromes. British journal of haematology, 1987, Volume: 65, Issue:4 Topics: Adult; Aged; Arginine; Bone Marrow; Female; Heme; Hemoglobins; Humans; Infusions, Intravenous; Leukocyte Count; Male; Myelodysplastic Syndromes; Neutrophils; Platelet Count	1987
ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Blood, 1995, Jun-01, Volume: 85, Issue:11 Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Chromosome Aberrations; Chromosome Deletion; Chromosomes, Human, Pair 11; Combined Modality Therapy; Dactinomycin; DNA-Binding Proteins; Etoposide; Female; Genes; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Myelodysplastic Syndromes; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Radiotherapy; Teniposide; Topoisomerase II Inhibitors; Transcription Factors; Translocation, Genetic; Whole-Body Irradiation	1995